Q3 2026 Investor Presentation
Released
Released
Announcement PDF
ASX:3DA
ASX Announcement
10 November 2026
1
Third Quarter 2026 Earnings Presentation
……………………………………………………………………………………………………………
Amaero Inc. (NASDAQ:AMRO; ASX:3DA) (“Amaero” or the “Company”) advises that further to the ASX
Announcement on 3 November 2026, the Company attaches its investor presentation for the quarter ended 30
September 2026.
This announcement has been authorised for release by the Chairman and CEO.
For further information, please contact:
Amaero Inc.
Brett Paduch
Chief Financial Officer
brett.paduch@amaeroinc.com
Media & Investor Enquiries in Australia
Jane Morgan
Director
jm@janemorganmanagement.com.au
Media & Investor Enquiries in United States
Shannon Devine
MZ Group
amaero@mzgroup.us
About Amaero
Amaero Inc. is a leading U.S.-based producer of high-value refractory and titanium alloy spherical powders for
additive manufacturing (“AM”) and advanced manufacturing, and a pioneer in Powder Metallurgy Hot Isostatic
Pressing (“PM-HIP”) manufacturing of large near-net-shape components utilized by the defense, space,
aviation, commercial nuclear and medical industries with manufacturing and corporate headquarters located in
Tennessee. We occupy a strategically critical position at the intersection of U.S. national security priorities that
include rebuilding a more resilient and more scalable defense industrial base, reshoring sovereign
manufacturing and supply chains and the adoption of additive and advanced manufacturing technologies. For
more information, visit our website: www.amaeroinc.com.
AMAERO INC.
Third Quarter 2026 Earnings Presentation
A leading U.S. domestic producer of high-value refractory and
titanium alloy spherical powders & manufacturer of near-net-
shape parts for mission-critical components
November 9, 2026
Important Notice and Disclaimer
This presentation has been prepared by Amaero Inc. ("Amaero" or the "Company") in connection with the release of its results for the third quarter ended September 30, 2026 and is intended to be
read together with the Company's earnings release dated November 9, 2026 and its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 filed with the U.S. Securities and
Exchange Commission (the "SEC"), including the "Risk Factors" contained therein. These documents are available free of charge on EDGAR at www.sec.gov and on the Company's investor website.
These are the Company's first quarterly results reported as a U.S.-domiciled, Nasdaq-listed company and are presented in U.S. dollars in accordance with U.S. generally accepted accounting
principles ("GAAP"). Comparative 2025 amounts, amounts for prior 2026 interim periods and fiscal year amounts are also presented in U.S. dollars in accordance with GAAP and may differ from
amounts previously reported by the Company on the ASX, which were prepared in Australian dollars in accordance with Australian Accounting Standards. Financial information contained in this
presentation is unaudited unless otherwise stated. Figures may not sum due to rounding.
This presentation may contain trademarks, service marks, trade names and copyrights of other companies, which are the property of their respective owners. Solely for convenience, some of the
trademarks, service marks, tradenames and copyrights referred to in this presentation may be listed without the TM, SM © or ® symbols, but Amaero will assert, to the fullest extent under applicable
law, the rights of the applicable owners, if any, to these trademarks, service marks, trade names and copyrights.
Unless otherwise indicated, all references in this presentation to "Amaero," the "Company," "we," "our," "us," or similar terms refer to Amaero Inc. and its subsidiaries.
This presentation includes Adjusted EBITDA, a non-GAAP financial measure. We define Adjusted EBITDA as income (loss) from continuing operations before interest, taxes, depreciation, and
amortization, further adjusted to remove the impact of stock-based compensation and costs related to the Redomiciliation, the IPO and preparation for the IPO. Adjusted EBITDA should not be
considered in isolation or as an alternative to loss from continuing operations, the most directly comparable GAAP measure, and may not be comparable to similarly titled measures presented by other
companies. A reconciliation of Adjusted EBITDA to loss from continuing operations is provided in the Appendix.
We provide backlog information in this presentation. Our backlog represents the portion of legally binding contracts that are expected to result in future revenue within the next twelve months and
supports predictable revenue expansion and facilitates forward revenue visibility. Backlog may also include change orders for any contracts that have been formally contracted. Our backlog consists of
firm orders for metal powder, which are not subject to any customer right of termination for convenience, and orders for PM-HIP components. Certain of our PM-HIP component contracts permit the
customer to terminate for convenience. In those cases, we are generally entitled to payment for work performed and costs incurred, subject to other adjustments, through the termination date,
determined under the applicable contract's terms. All backlog information in this presentation is as of September 30, 2026 unless otherwise noted.
This presentation includes forward-looking statements that reflect our intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition, liquidity,
performance, prospects, growth, strategies and the industry in which Amaero operates. Such forward-looking statements include, without limitation, statements regarding our financial guidance for
2026, the growth of our revenue, production, and backlog, the conversion of backlog into revenue, the performance and completion of existing contracts, capital deployment and operating cash usage,
the sufficiency of our cash resources and our need for additional funding, the timing of commissioning of our fourth EIGA Premium atomizer and argon gas recycling system and their planned
capabilities, plans to advance the qualification of our components through collaborations with Bechtel Plant Machinery and the U.S. Navy, and progress towards completion of our development
program with the U.S. Department of War. These forward-looking statements are subject to risks, uncertainties and assumptions, including those described under "Risk Factors" in our Quarterly Report
on Form 10-Q. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those made in or suggested by the forward-looking statements
contained in this presentation as a result of numerous factors, many of which are beyond our control. Investors should note that past performance may not be indicative of results or developments in
future periods. We do not undertake any obligation to update or revise any forward-looking statements in this presentation, except as required by applicable law or regulation.
2
Business Overview
Hank J. Holland
Chairman and Chief Executive Officer
Amaero at a Glance
3
Commissioned
Atomizers
1
Ordered
Atomizer
191%
YoY Revenue
Growth
(Q3 2026 TTM)
$13.4M(2)
Backlog
(~100% of Q3 2026
TTM Revenue)
KeyMetrics
• High-purity spherical titanium powder for defense, aerospace, medical and
consumer applications
Titanium Alloy Powder
• PM-HIP manufactured near-net-shape parts, providing a shorter-cycle alternative
to constrained casting and forging supply chains
PM-HIP Components
________________________
(1) Titanium powder capacity expected to increase to 720 MT per year upon commissioning of a fourth
EIGA Premium atomizer in June 2027, bringing maximum powder capacity to 920 MT per year.
(2) As of September 30, 2026. See Important Notice and Disclaimer for a definition of backlog.
Amaero is a U.S.-domestic advanced materials and manufacturing platform positioned at the intersection of
defense, reshoring, and additive manufacturing
• High-temperature specialty powders for defense, space and commercial nuclear
energy
Refractory Alloy Powder
480
MT / year Current
Titanium Powder
Capacity(1)
200
MT / year
Current Refractory
Powder Capacity
+
4
ProductLines
Platform Strengths
Powder and PM-HIP production at Amaero’s Tennessee plant, filling a gap in America’s
manufacturing and supply chain for defense, space, aerospace, commercial nuclear and
industrial sectors
Three atomization lines are running today, with a fourth on order that is expected to be
commissioned in June 2027. Expanded custom-designed and fabricated sieving system
commissioned in August 2026.
Q3 2026 YTD revenue equaled $11.5MM, increase of 170% over same period in 2025,
with multi-year exclusive supplier agreements, as well as contracts with DoW and BPMI
Why We Matter
5
Domestic production scale, proprietary PM-HIP know-how and an owner culture position Amaero to capture
rising demand for sovereign manufacturing and supply chains
Our Differentiators
01 Largest U.S. domestic production capacity
for high-value refractory and titanium spherical
powders
02 Pioneering experience in PM-HIP
manufacturing of near-net-shape parts
03 Leading technical team that brings deep
proprietary know-how in powder metallurgy,
powder production and advanced manufacturing
04 Equity-ownership culture and commitment to
excellence
Four Tailwinds Behind Our Growth
Critical bottlenecks in sovereign
manufacturing and supply chains,
including forgings
More resilient and scalable
sovereign defense industrial base
Mid-stream processing and
production for critical minerals
Adoption of 3D printing
and advanced
manufacturing
AMAERO
From Spin-Out to U.S. Sovereign Manufacturer
From an Australian additive manufacturing services start-up to the largest U.S. domestic production
capacity for refractory and titanium alloy powders and pioneering PM-HIP manufacturing know-how
Australian Origins
2013 – 2021
Recap & U.S. Pivot
2022 – 2023
Build-Out & Scale-Up
2024 – 2025
Redomiciliation & Listing
2026 – 2027E
2013
Amaero is founded as the
commercial arm of Monash
University's Centre for
Additive Manufacturing
May 2022
Pegasus Growth Capital (led
by Hank Holland) anchors
A$8M+ capital raise at
A$0.21 per share
Jun 2024
First EIGA premium atomizer
commissioned, dedicated to
refractory and specialty alloys
Jun 2026
Third atomizer
commissioned; fourth
atomizer and argon recycling
contracted
December 2019
ASX IPO at A$0.20 per
share; A$8M raised
Sep 2022
Hank Holland appointed as
Executive Chairman, later
assumes CEO role. Pegasus
underwrites and leads
additional capital raises.
Jun 2025
Second EIGA atomizer
commissioned, dedicated to
titanium alloy powders
Jun 2026
U.S. redomiciliation
completed, ASX listing
retained via CDIs
2019 – 2021
Additive manufacturing
business starts to grow and
pivot to titanium powder
begins
Jul 2023
McDonald, Tennessee
selected as the new
manufacturing site
Aug 2025
A$50M institutional
placement at A$0.40 per
share
Oct 2026
Completed U.S. IPO and
Nasdaq listing (AMRO)
6
Ti Powder Refractory Powder PM-HIP
+ +
Hank Holland
Chairman and Chief
Executive Officer
Experienced Leadership with Deep Technical Expertise
Seasoned executives backed by leading technical team in powder metallurgy, gas atomization and PM-HIP
LeadershipTeam
Executive Spotlight
Hank Holland is a career investor who
previously held senior roles at First
Republic Investment Management, Merrill
Lynch and Sanford C. Bernstein & Co.
Prior to joining Amaero, Holland built and
managed one of the largest private
wealth practices in the United States
Holland founded Pegasus Growth Capital
using personal capital to invest in
strategically important industrial
businesses
In 2022, Amaero was brought to
Holland’s attention as the Company
addressed one of the primary bottlenecks
in the defense sector – domestic
production of specialty alloy powders
Holland, through his investment fund,
Pegasus Growth Capital, has led and
underwritten prior capital raises for
Amaero, aligning his interests with those
of other shareholders, and believes the
Company will make a durable
contribution to U.S. national security
Eric
Bono
Chief
Technology
Officer
Brett Paduch
Chief Financial Officer
Mick Maher
Chief Strategy &
Commercial Officer
Technical Expertise
Dr. Ron
Aman
VP, Technical
Solutions
Dr. Arun
Chattopadhyay
VP, Manufacturing &
Development
Fred
Yolton
Fellow – Powder
Metallurgy &
Materials
Engineering
Dr. Jonathan
Pegues
VP, Technology
Development
Melissa Denton
Chief Administrative
Officer
Dr. Dave
Schmidt
Director
Computational
Analysis
7
Strategy: Subscale Markets, Defensive Moat
8
We focus on critical supply-chain bottlenecks and build proprietary capabilities
Why Subscale Markets
Subscale market at a
critical bottleneck
Limited competitive
landscape
Specialty margin
structure
Higher enterprise
valuation multiple
1st-Mover Advantage + High Barriers to Entry = Defensive Moat
1st-Mover Advantage
• Largest U.S. domestic
capacity for refractory and
titanium spherical powders
• First PM-HIP low-rate initial
production (LRIP) contract
after 2+ years of development
with BPMI and the U.S. Navy
• $4.5M DoW contract to
develop alternative refractory
alloy powders
High Barriers to Entry
• Customer qualifications,
including C103 qualified for
manned space flight
• Proprietary know-how in EIGA
Premium commissioning, retrofit
and process tuning
• $52.2M invested in plant and
equipment at an AS9100D-
certified facility
Defensive Moat
• Few competitors in subscale
markets with long qualification
cycles
• Long-term agreements and
$13.4M backlog, up 180% YoY
• Domestic, sovereign supply for
U.S. defense and aerospace
programs
+ =
Leading Technology Coupled with Proprietary Know-How
While EIGA Premium provides the underlying platform, our technical team delivers superior powder
performance through proprietary commissioning, retrofit customization, and process tuning
Commercially viable reactive powders require technical expertise – not just equipment
DifferentiatedProcess
Amaero EIGA Premium
Conventional
Point of Difference
Crucible-Free / Non-Contact
Crucible / Refractory
Contact
Melting Method
Designed to Minimize
Pick-Up
Oxygen and Nitrogen
Pick-Up
Contamination
~2x Usable Yield on
~50% of the Gas
Baseline
Process Efficiency
Only Method Qualified at
Scale
Contamination May Exceed
Tolerable Limits
Refractory Alloys (C103)
Why Our Advantage is Defensible
Qualification & Talent
NASA & AFRL Validation
EIGA Premium Economics
9
2x 77%
½
Usable
Powder Yield
Gas Usage
vs. Conventional
Atomizers
Minimum Cost
Reduction Using
Argon Recycling(1)
C103 67
2+
Qualified with
ADDMAN &
NCAME
Years of PM-HIP
Development with
BPMI & U.S. Navy
Employees at
the TN Facility
“Non-contact EIGA is the industry
standard for reactive and refractory
materials.”
– Dr. Mark Benedict, Senior Scientist, Air Force
Research Laboratory
________________________
(1) Planned capability; not representative of current capability.
Upon Equipment Commissioning After Proprietary Modifications
Mission-Critical End Markets
10
Our powders and PM-HIP parts serve priority defense programs and commercial markets that need
qualified, domestic supply
Naval Nuclear and
Priority Defense
Systems
• PM-HIP near-net-shape parts for
the U.S. submarine industrial base
• First LRIP contract with BPMI in
July 2026
Hypersonic, Strategic
Missile and Missile
Defense
• Refractory alloy powders, including
C103, for high-temperature
applications
• $4.5M DoW alternative refractory
alloy program
Commercial Nuclear
• PM-HIP components as an
alternative to constrained castings
and forgings
Aerospace
• Titanium alloy powder for aircraft
structures and jet engine
components
Medical Device and
Orthopedics
• High-purity titanium powder for
additively manufactured implants
Consumer Electronics
• Titanium powder for additively
manufactured device components
Our Customers(1)
Diversified Customer Base
11
Our customer base spans defense primes, shipbuilders, commercial additive manufacturers, national
laboratories, and U.S. government programs.
________________________
(1) Representative list of current and recent customers; not intended to be exhaustive.
Foundational Buildout Completed
12
With the core plant in place, Amaero is shifting from build-out to scaling production
________________________
(1) Twelve months ended June 30, 2026, Amaero's first year of commercial production following
commissioning of its first titanium EIGA Premium atomizer in June 2025.
(2) As of September 30, 2026. See Important Notice and Disclaimer for a definition of backlog.
Plant & Equipment
$52.2M
Gross PP&E as of Sep. 30,
2026, invested to complete the
foundational buildout
First Year of Commercial
Production(1)
$12.5M
Revenue for the twelve months
ended June 30, 2026
Backlog and Pipeline(2)
$13.4M
+180% YoY and +96% since
Dec. 31, 2025, with a growing
customer pipeline
U.S. Listing
AMRO
Completed redomiciliation, U.S.
IPO and Nasdaq listing; $17.0M
net IPO proceeds
THROUGH Q3 2026 Foundational Buildout Q4 2026 AND BEYOND Scaling Production and Growth
• Three EIGA Premium atomizers with ~680 MT of annual
capacity: ~480 MT titanium and ~200 MT refractory
• Titanium throughput capacity doubled with the third
atomizer and expanded sieving system in 2026
• PM-HIP moved into low-rate initial production with BPMI
for the U.S. submarine industrial base
• Growing backlog and pipeline position Amaero for strong
year-over-year commercial growth
• Q4 2026 guidance of $4.5M–$5.0M implies full year 2026
revenue of $16.0M–$16.5M, up 154%–162%
• Argon gas recycling (Q1 2027) and fourth EIGA (June
2027) on track to add capacity and lower cost
• Fixed production costs largely in place, so revenue growth
is expected to drive operating leverage
• Completed a comprehensive process, system, and facility safety review with
Jensen Hughes, a leader in safety, dust hazards and risk-based engineering,
and implemented remediation and improvements
• Titanium powder production resumed in late July after an approximately six-
week pause
• No purchase order cancellations during or following the production pause, and
no employee attrition during the pause
• Custom-designed titanium sieving system commissioned in August; with the
third EIGA Premium atomizer, it expanded titanium throughput capacity by
~100%
• Commissioned third EIGA Premium atomizer in June 2026
• Now operating three EIGA Premium atomizers: one refractory and two titanium,
representing annual capacity of ~200 MT refractory and ~480 MT titanium
• Argon gas recycling system on track for commissioning Q1 2027; fourth EIGA
on track for commissioning June 2027
Operational and Production Update
13
Progress on Strategic Initiatives
14
Progress
Milestone
Status
Initiative
Amaero Inc. (Delaware) replaced Amaero Ltd as parent company
June 2026
Complete
U.S. redomiciliation
Trading as AMRO since October 15; $17.0M net IPO proceeds
October 2026
Complete
Nasdaq listing
Three atomizers now operating: ~480 MT titanium and ~200 MT
refractory capacity
June 2026
Complete
Third EIGA Premium atomizer
With the third atomizer, doubled titanium throughput capacity
August 2026
Complete
Titanium sieving system
First BPMI low-rate initial production contract; first LRIP revenue in
Q3
July 2026
Complete
PM-HIP into production
$4.5M contract ($4.4M in backlog); two high-temperature alloys
down-selected and produced
August 2027
In progress
DoW refractory alloy program
Targets at least a 77% cut in argon costs; $1.5M of payments
remain
Q1 2027
On track
Argon gas recycling system
Lifts powder capacity to 920 MT / year; $1.7M of payments remain
June 2027
On track
Fourth EIGA Premium atomizer
Redomiciliation, Nasdaq listing, third atomizer and sieving system are complete; both 2027 capacity
projects are on schedule
________________________
Milestone shows completion date for completed items and expected completion date for items in progress.
Remaining payments are contracted capital commitments as of September 30, 2026.
Q3 2026 Results and
Outlook
Brett Paduch
Chief Financial Officer
Hank J. Holland
Chairman and Chief Executive Officer
Q3 2026 Highlights
16
Revenue grew 35% and backlog nearly tripled YoY
________________________
(1) As of September 30, 2026. See Important Notice and Disclaimer for a definition of backlog.
(2) Includes cash and cash equivalents excluding restricted cash.
Revenue
$4.1M
+35% vs. $3.1M in Q3
2025
9M YTD Revenue
$11.5M
+170% vs. $4.3M in 9M
YTD 2025
Cash Use Reduction
$1.0M
Op. cash use of $6.3M
vs. $7.3M in Q3 2025
Cash Balance(2)
$19.3M
At Oct. 31, 2026, after
October operating cash
use and capex
Commercial Progress
• $4.5M U.S. Department of War
contract to develop alternative
refractory alloy powders, awarded in
July
• First BPMI LRIP contract, valued at
$0.3M, moved PM-HIP from
development into production
• PM-HIP revenue up 146% to $0.9M,
including first LRIP revenue
Operational Execution
• Titanium production resumed in late
July after an approximately six-week
safety pause, with no order
cancellations during or since the pause
and no staff attrition
• Titanium throughput capacity
doubled with the new sieving system
and third EIGA Premium atomizer
• Jensen Hughes safety review
completed and remediation
implemented
Capital Markets
• Listed on Nasdaq (AMRO) on Oct. 15;
$17.0M net IPO proceeds received
• EXIM amendment released $2.1M of
restricted cash and moved liquidity
covenant test to 2028
• $19.3M cash and cash equivalents at
Oct. 31, 2026, after October operating
cash use and capex
Backlog(1)
$13.4M
+180% vs. $4.8M at Sep.
30, 2025
Revenue Guidance and Outlook
17
YoY Growth
Current Outlook
Prior Period
Revenue ($ in millions)
121% – 146%
$4.5 – $5.0
$2.0
Q4 2026 Guidance
Oct.–Dec. 2026
69% – 79%
$8.6 – $9.1
$5.1
Second Half 2026 – Includes Q4 Guidance
Jul.–Dec. 2026
154% – 162%
$16.0 – $16.5
$6.3
Full Year 2026 – Includes Q4 Guidance
Jan.–Dec. 2026
Q4 2026 guidance of $4.5M–$5.0M implies full year 2026 revenue of $16.0M–$16.5M, up 154%–162%
________________________
Implied periods combine Q4 2026 guidance with reported revenue. Guidance is forward-looking; see Important
Notice and Disclaimer.
Key Assumptions
• $13.4M backlog expected to convert to
revenue within twelve months
• Titanium output running on two atomizers
with doubled throughput capacity
• DoW program revenue recognized over
time through August 2027
Change from Prior Outlook
• First formal guidance as a U.S.-listed
company
• Prior disclosure was the preliminary Q3
range in the October prospectus; Q3
revenue landed near top of range
Management Outlook
• Bring capacity online: argon recycling in
Q1 2027 and fourth EIGA in June 2027
• Deepen partnerships with defense and
aerospace customers
• Convert backlog into revenue
Q3 2026 Results vs. Preliminary Ranges
18
vs. Range
Actual
Prelim. High(1)
Prelim. Low(1)
Q3 2026 ($ in thousands)
GAAP Financial Measures
Near top of range
$4,113
$4,120
$3,960
Revenue
Within range
$4,959
$4,960
$4,950
Cash and cash equivalents(2)
Favorable to range
$(9,057)
$(9,070)
$(9,500)
Net loss attributable to stockholders
Key Performance Indicators and Non-GAAP Financial Measures
Within range
$13,437
$13,440
$13,430
Backlog(3)
Favorable to range
$(6,340)
$(6,350)
$(6,540)
Net cash used in operating activities
Favorable to range
$(7,114)
$(7,240)
$(7,610)
Adjusted EBITDA(4)
Revenue landed near the top of the previously disclosed range; net loss, operating cash use and Adjusted
EBITDA were favorable to the range
________________________
(1) Preliminary, unaudited estimated ranges included in the Company's final prospectus dated October 14,
2026 and filed with the Securities and Exchange Commission on October 15, 2026.
(2) Does not reflect the release of approximately $2.1 million of restricted cash under the October 2026
amendment to the EXIM Bank Credit Agreement.
(3) See Important Notice and Disclaimer for a definition of backlog.
(4) Adjusted EBITDA is a non-GAAP financial measure. See the Appendix for a reconciliation to loss from
continuing operations.
$1.0 $1.5 $1.9 $2.4
$5.3 $6.4
$10.6 $11.1
$6.3
$7.8
$12.5
$13.5
Q4 2025 Q1 2026 Q2 2026 Q3 2026
Powder
PM-HIP
$0.3 $0.6 $0.6 $0.9
$1.7 $1.3
$4.9
$3.2
$2.0 $1.9
$5.5
$4.1
Q4 2025 Q1 2026 Q2 2026 Q3 2026
Revenue Performance
TTM Revenue
USD, millions
Powder
PM-HIP
Quarterly Revenue
USD, millions
YoY Growth
418% 431% 538% 35%
YoY Growth
369%
379% 438% 191%
Financial Highlights
TTM Revenue
$13.5 million
Up 191% vs. Q3 2025 TTM
Q3 2026 Revenue
$4.1 million
Up 35% vs. Q3 2025
Backlog(1)
$13.4 million
Up 180% from $4.8 million
as of Sep. 30, 2025
DoW Contract Award
$4.5 million
13-month program for the development of
alternative refractory alloy powders
19
________________________
(1) Current backlog is as of September 30, 2026. See Important Notice and Disclaimer for a definition of backlog.
Source: Q4 2025–Q2 2026 revenue per the Company’s final prospectus dated October 14, 2026 (Reg. No. 333-298612), Quarterly Results of Operations; Q3 2026
per unaudited financial statements. Q1–Q2 2026 product split derived from nine-month results.
Q3 revenue rose 35% to $4.1M, and PM-HIP more than doubled to $0.9M
Q4 2025 Q1 2026 Q2 2026 Q3 2026
Q3 and Year-to-Date Financial Summary
20
Nine Months Ended Sep. 30
Three Months Ended Sep. 30
($ in thousands, except per share)
YoY
2025
2026
YoY
2025
2026
166%
$3,537
$9,396
19%
$2,679
$3,201
Metal powders
189%
732
2,114
146%
371
912
PM-HIP components
170%
$4,269
$11,510
35%
$3,050
$4,113
Total revenue
150%
7,638
19,078
170%
3,142
8,493
Cost of revenue
-
$(3,369)
$(7,568)
-
$(92)
$(4,380)
Gross loss
48%
9,543
14,127
15%
3,727
4,276
Selling, general and administrative
(27)%
274
201
(48)%
266
138
Research and development
(10)%
120
108
-
120
-
Loss on dispositions and impairment
-
$(13,306)
$(22,004)
-
$(4,205)
$(8,794)
Loss from operations
-
$(12,826)
$(22,490)
-
$(4,096)
$(9,057)
Net loss attributable to stockholders
-
$(0.72)
$(0.94)
-
$(0.20)
$(0.38)
Net loss per share, basic and diluted
-
$(10,722)
$(15,625)
-
$(3,072)
$(7,114)
Adjusted EBITDA(1)
________________________
(1) Adjusted EBITDA is a non-GAAP financial measure. See the Appendix for a reconciliation to loss from
continuing operations.
Nine-month revenue rose 170% to $11.5M
Key Takeaways
21
Revenue and backlog are growing while the capacity build stays on schedule
Contains forward-looking statements. See Important Notice and Disclaimer.
01 Revenue grew 35% year over year
Q3 revenue rose 35% to $4.1M, near the top of the prospectus range, and nine-month revenue rose 170% to $11.5M
02 Forward visibility improved
Backlog of $13.4M is 2.8x the prior year, and Q4 2026 guidance implies full year 2026 revenue of $16.0M–$16.5M, up
154%–162%
03 Margins depend on titanium utilization
Q3 gross loss reflects the late-July titanium restart and lower yields while the new sieving system was optimized; with
titanium throughput capacity doubled, higher output spreads fixed production costs
04 The capacity build is on schedule
Argon recycling (Q1 2027) and the fourth EIGA (June 2027) are on track, funded in part by $17.0M of October net IPO
proceeds
Appendix
Adjusted EBITDA Reconciliation
23
Nine Months Ended Sep. 30
Three Months Ended Sep. 30
($ in thousands)
2025
2026
2025
2026
$(12,997)
$(22,490)
$(4,097)
$(9,057)
Loss from continuing operations
(403)
(482)
(168)
(94)
Interest income
170
1,176
132
479
Interest expense
—
—
—
—
Income tax expense (benefit)
753
1,527
369
592
Depreciation and amortization
1,755
2,016
692
322
Stock-based compensation
—
2,628
—
644
IPO-related costs(1)
$(10,722)
$(15,625)
$(3,072)
$(7,114)
Adjusted EBITDA
Reconciled to loss from continuing operations, the most directly comparable GAAP measure
________________________
(1) Represents non-ordinary course costs incurred related to the Redomiciliation and preparation for and costs related to the IPO.
Adjusted EBITDA is income (loss) from continuing operations before interest, taxes, depreciation and amortization, further adjusted to remove stock-based compensation and Redomiciliation and IPO-related costs. See
Important Notice and Disclaimer.
(ASX: 3DA | OTC: AMROF)
Share your feedback
Discover